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Abstract: A fatal case associated with enterovirus D68 (EV-D68) infection affecting a 10-year-old
boy was reported in Hong Kong in 2014. To examine if a new strain has emerged in Hong Kong,
we sequenced the partial genome of the EV-D68 strain identified from the fatal case and the complete
VP1, and partial 5′UTR and 2C sequences of nine additional EV-D68 strains isolated from patients in
Hong Kong. Sequence analysis indicated that a cluster of strains including the previously recognized
A2 strains should belong to a separate clade, clade D, which is further divided into subclades
D1 and D2. Among the 10 EV-D68 strains, 7 (including the fatal case) belonged to the previously
described, newly emerged subclade B3, 2 belonged to subclade B1, and 1 belonged to subclade D1.
Three EV-D68 strains, each from subclades B1, B3, and D1, were selected for complete genome
sequencing and recombination analysis. While no evidence of recombination was noted among local
strains, interclade recombination was identified in subclade D2 strains detected in mainland China in
2008 with VP2 acquired from clade A. This study supports the reclassification of subclade A2 into
clade D1, and demonstrates interclade recombination between clades A and D2 in EV-D68 strains
from China.
Keywords: enterovirus D68; clade; recombination
1. Introduction
Enterovirus D68 (EV-D68) belongs to enterovirus species D (EV-D) in the genus Enterovirus of
the family Picornaviridae. EV-D68 was first isolated from hospitalized children with lower respiratory
illnesses in California in 1962 [1], and human rhinovirus 87 was later confirmed as an isolate of EV-D68
based on antigenic and genetic characterization and acid lability testing [2]. Sporadic cases of EV-D68
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infection have been reported since 1970 [3], but there has been a significant increase in the number of
reports of EV-D68 circulating globally in recent times [4–11]. In 2014, a nationwide outbreak of EV-D68
associated with severe respiratory disease in children and acute flaccid myelitis occurred in the United
States (US), affecting over 1100 people in 49 states, 14 of whom died [12]. Most of the EV-D68 strains
detected in the US outbreak belonged to clade B1, especially those sampled from acute flaccid myelitis
(AFM) cases [13]. In our previous study, we examined the clinical and molecular epidemiology of
EV-D68 among hospitalized patients with respiratory tract infections in Hong Kong [14]. Phylogenetic
analysis of partial VP1, 2C, and 3D regions of EV-D68 strains in Hong Kong revealed four distinct
lineages, clade A1, A2, B1, and the new clade, B3, with the elderly having severe lower respiratory
illness exclusively caused by clade A2 [14]. Moreover, strains closely related to the US 2014 outbreak
B1 strains were detected as early as 2011 in Hong Kong. These findings suggested that EV-D68 has
been evolving into new lineages that might be emerging.
Mutations and recombinations are well-known phenomena in driving enterovirus evolution [15–18].
However, to date, only one study has demonstrated an intraclade recombination event within an
EV-D68 strain US/KY/14-18951, which has arisen from recombination between subclades B1 and
B2 [19]. In 2014, there was a fatal case associated with EV-D68 infection in a 10-year old boy in Hong
Kong. To determine if a new strain has emerged in Hong Kong and if recombination events have
played a role in the evolution of the emergence of new EV-D68 strains in Hong Kong, we sequenced
the partial genome of the EV-D68 strain detected from the fatal case. We also randomly selected nine
additional EV-D68 strains isolated from patients in Hong Kong during 2012 to 2014 and sequenced
their complete VP1, partial 5′ untranslated region (5′UTR), and 2C region. We also determined the
complete genome sequences of three EV-D68 strains belonging to three different clades, B1, B3, and D1.
2. Results
2.1. Clinical Characteristics of Patients with Enterovirus D68 (EV-D68) Infections
The fatal case occurred in a 10-year-old boy (case 1) with an α-thalassemia trait who was
residing in mainland China and presented with acute encephalitis, neurogenic pulmonary edema
with respiratory failure, autonomic dysfunction, and cardiac arrest requiring intensive care in August
2014 (Table 1). Due to the critical condition and coagulopathy state, lumbar puncture could not
be performed. Therefore, he was started on broad-spectrum antimicrobial coverage for possible
meningoencephalitis while awaiting investigation results. His condition was complicated by severe
hypoxic ischemic encephalopathy and he died nine days after admission despite use of broad-spectrum
antimicrobials including cefotaxime, tazobactam-piperacillin, vancomycin, levofloxacin, and acyclovir.
Mycoplasma pneumoniae and EV-D68 nucleic acids were detected by PCR in his nasopharyngeal
aspirate (NPA). The M. pneumoniae showed an A2063G mutation indicating macrolide resistance [20].
His peri-mortem cerebrospinal fluid (CSF) obtained after developing confusion and respiratory
deterioration was negative for EV-D68 RNA.
Nine other EV-D68 strains were isolated from the nasopharyngeal swabs (NPSs) or NPAs, obtained
as part of the diagnostic workup of hospitalized patients from seven regional hospitals in Hong Kong
from 2012 to 2014. Including the fatal case, most patients with EV-D68 infections were young children,
while one was an elderly female patient (median age 4.5 years, range 2–94 years). Six were male and
four were female. The clinical characteristics of the 10 patients with EV-D68 infections are summarized
in Table 1. The 94-year-old woman with underlying medical illnesses presented with pneumonia.
Six of the young children presented with upper respiratory tract infections (URTI), among which four
were complicated by asthmatic exacerbation and one was complicated by Henoch Schonlein purpura.
Two other children presented with wheezy bronchitis and febrile wheeze, respectively. Except for one
fatal case, the other nine patients survived.
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Table 1. Clinical characteristics of the 10 cases of enterovirus D68 (EV-D68) infections.
Case Strain SpecimenType Collection Date Gender Age Underlying Diseases Diagnosis Clade
1 V14-8157864 NPA 16 August 2014 M 10 α-thalassemia trait
Encephalitis,
Mycoplasma pneumoniae
co-infection
B3 #
2 V12-2240471 NPS 7 May 2012 M 5 Allergic rhinitis URTI, asthma B1
3 V12-2268728 * NPA 20 July 2012 M 2 None URTI, asthma B1
4 V13-2245157 * NPS 21 May 2013 F 94 HT, CVA, gout, dementia Pneumonia D1
5 V14-8133616 NPA 18 May 2014 M 4 Allergic rhinitis, asthma URTI, asthma B3
6 V14-8135150 NPA 23 May 2014 F 4 MRSA skin infection URTI, RSV co-infection B3
7 V14-8143594 NPS 21 June 2014 F 4 Eczema Wheezy bronchitis B3
8 V14-8143833 NPS 24 June 2014 F 4 None URTI, asthma B3
9 V14-8151518 NPS 23 July 2014 M 5 α-thalassemia trait URTI, HenochSchonlein purpura B3
10 V14-8151546 * NPS 23 July 2014 M 5 None Febrile wheeze B3
* EV-D68 strains selected for complete genome sequencing. # VP1 sequence not available; partial 5′UTR and 2C
were sequenced (100% identical to those of EV-D68 strain V14-8151546; potential subclade B3). Abbreviations: CVA,
cerebrovascular accident; HT, hypertension; MRSA, methicillin-resistant Staphylococcus aureus; NPA, nasopharyngeal
aspirate; NPS, nasopharyngeal swab; RSV, respiratory syncytial virus; URTI, upper respiratory tract infection; M:
male; F: female.
2.2. Complete VP1 Gene Sequence Analysis
Since the strain V14-8157864 from the fatal case could not be grown in cell culture, only partial
genomic sequences could be obtained and the complete VP1 sequence was not available. On the other
hand, the complete VP1 sequences of the other nine EV-D68 virus isolates were successfully obtained.
Phylogenetic analysis showed that they fell into three different subclades of EV-D68. Eight EV-D68
strains were clustered with other EV-D68 strains of clade B (Figure 1A). Among these eight strains,
two strains from the year 2012 belonged to subclade B1 (nucleotide divergence of 0.2–3.5% for strains
within B1), while six strains from the year 2014 belonged to subclade B3 (nucleotide divergence of
0.1–2.7% for strains within B3). The nucleotide divergence of 2.6–5.3% was observed between subclade
B1 and subclade B3 strains (Table 2).
Table 2. Nucleotide sequence identities of VP1 genes between clades and subclades of EV-D68 strains.
Strains * Pairwise Identity (%) Average Nucleotide Divergence (%) [Range]
Interclade 10.8 [6.5–14.8]
Prototype vs. A 87–87.9
Prototype vs. B 85.5–86.6
Prototype vs. C 87.8–88
Prototype vs. D 85.2–86.7
A vs. B 86.5–90.4
A vs. C 88.8–91.4
A vs. D 90.2–93.5
B vs. C 89.8–93.1
B vs. D 86.4–89.7
C vs. D 87.9–90.5
A vs. D1 90.2–91.7
A vs. D2 91.8–93.5
Intersubclade 4.7 [2.6–7.1]
B1 vs. B2 94–95.2
B1 vs. B3 94.7–97.4
B2 vs. B3 92.9–94.2
D1 vs. D2 94.1–95.6
Intrasubclade 1.4 [0–3.5]
B1 96.5–99.8
B2 98.9–100
B3 97.3–99.9
D1 97.5–99.7
D2 98.1–99.6
* VP1 sequences of the EV-D68 strains used for the analysis are shown in Table A1 in Appendix A.
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Figure 1. Phylogenetic analysis using VP1, partial 5′UTR and 2C gene sequences of enterovirus D68
(EV-D68) strains.The trees were inferred from (A) VP1, (B) partial 5′UTR and (C) partial 2C sequence
data by the maximum likeliho d (ML) method, with bo tstrap values calculate fro 1000 trees.
Sequences for 918 nucleotide positions in each VP1 region, 356 nucleotide positions in each 5′UTR
region, and 531 nucleotide positions in each 2C region were included in the analysis. Bo tstrap values
expres ed as a percentage are shown at the nodes and the scale reflects the number of nucleotide
substitutions per site along the branches. Only bo tstrap values >70% are shown. Black circles indicate
EV-D68 strains col ected for the res t .
One EV-D68 strain from the only elderly case (case 4) in this study was most closely related to
subclade A2. However, recent studies demonstrated that the previously recognized A2 strains should
be classified as clade D [21,22]. This was further supported by our in-silico analysis, in which (1) the
nucleotide sequence divergence of 6.5–9.8% was observed between clade A and clade D strains (similar
to that between other clades) (Table 2); (2) the strains in clade D formed a distinct cluster from clade
A strains supported by a high bootstrap value of 97% (Figure 1A); and (3) amino acid residues in
several positions of the VP1 of clade D strains were different from those of clade A strains (Table 3).
Intriguingly, two distinct clusters were noted in clade D (Figure 1A), with nucleotide divergence of
4.4–5.9% between strains of the two clusters (Table 2). Moreover, amino acid residues in positions
5, 6, 103, and 279 of the VP1 were different between strains of these two clusters (Table 3). These
findings suggested that these two clusters should be classified as subclade D1 and D2 (Figure 1A). Thus,
the “A2” strain (case 4) in this study should also belong to subclade D1 (Figure 1A). This and other
subclade D1 strains had a high degree of VP1 nucleotide sequence identity of 97.5–99.7% (Table 2).
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Table 3. Amino acid residues of VP1 between EV-D68 strains for clade A and D differentiation.
Strains
Positions
2 5 6 92 103 131 140 142 147 177 186 279 C-terminus
Clade A
CA/RESP/10-786 D D A A F V S S T A I R VTT
NZ-2010-541 D D A A F V S S T A I R VTT
NYC403 D D A A F V S S T A I R VTT
TW-02378_2010 D D A A F V S S T A I R
ITA/19391/12 D H A A F V S S T A I R
HK2/2010 D D A A F V S S T A I R VTT
Clade D
Subclade D1:
TW-02722_2013 E H E T Y I G N M G V K RLVNT
US/KY/14-18953 E H E T Y I G N M G V K RLVNT
2011-21286 E H E T Y I G N M G V K RLVNT
2012-12225 E H E T Y I G N M G V K RLVNT
2013-1017-26 E H E T Y I G N M G V K RLVNT
HK5/2011 E H E T Y I G N M G V K RLVNT
HK13/2012 E H E T Y I G N M G V K RLVNT
HK21/2013 E H E T Y I G N M G V K RLVNT
V13-2245157 E H E T Y I G N M G V K RLVNT
Subclade D2:
BCH895A E D A T F I G N M G V R RLVNT
BJ24 E D A T F I G N M G V R RLVNT
TW-01166_2007 E D A T F I G N M G V R
TW-11134_2009 E D A T F I G N M G V R
1737-Yamagata-2008 E D A T F I G N M G V R RLVNT
The VP1 amino acid residues of EV-D68 subclade D1 different from those of subclade D2 are highlighted in grey.
Amino acid code: D, aspartic acid; A, alanine; F, phenylalanine; V, valine; S, serine; T, threonine; I, isoleucine;
R, arginine; E, glutamic acid; H, histidine; Y, tyrosine; G, glycine; N, asparagine; M, methionine; K, lysine; L, leucine.
2.3. Partial 5′UTR and 2C Sequence Analysis
Although the VP1 of the strain V14-8157864 from the fatal case (case 1) could not be amplified,
the partial 5′UTR and 2C gene region of this strain and the other nine EV-D68 strains from Hong
Kong were all successfully amplified and sequenced. Phylogenetic analysis using the partial 5′UTR
and 2C sequences (Figure 1B,C) showed similar topologies to those using VP1 sequences. The strain
V14-8157864 from the fatal case was clustered with B3 strains.
2.4. Complete Genome Analysis of Local and Regional EV-D68 Strains
To look for potential mutation and recombination events among EV-D68 strains in Hong Kong,
one strain belonging to each subclade (B1, B3, and D1) were selected for complete genome sequencing
(Table 1). The three genomes are around 7.3 kbp in length, after excluding the polyadenylated
tract, and the G + C content is 42%. Two deletions (CCTCAAAACCTCCAGTACATAAC and
AAACTTATTTAT corresponding to positions 682–704 and 718–729 of the prototype strain Fermon,
respectively) in the spacer region of 5′UTR between the end of the internal ribosome entry site and the
start codon of the open reading frame were noted in strains belonging to clades B and C when compared
to the prototype strain Fermon [23], while only the first deletion (CCTCAAAACCTCCAGTACATAAC)
was observed in strains belonging to clades A and D (Figure 2).
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Figure 2. Deletion blocks in 5 UTR of EV-D68 strains. Nucleotides 672–742 (based on the prototype
strain with GenBank accession no. AY426531) of the 5 UTR are shown. EV-D68 representative strains
of clade A, B, C, D, and the prototype strain Fermon are included.
To examine for incongruent tree topologies which may suggest potential recombination events,
phylogenetic trees using nucleotide sequences of VP4 to VP1, 2A to 2C, and 3A to 3D regions of three
EV-D68 strains from Hong Kong and other EV-D68 strains with complete genome sequences available
in the GenBank were constructed (Figures 1A and 3). The results did not reveal potential recombination
in the three Hong Kong strains, and confirmed that V13-2245157 belonged to clade D1, while
V12-2268728 and V14-8151546 belonged to clades B1 and B3, respectively (Figures 1A and 3). A study
showed that the majority of the outbreak strains belonging to subclade B1 in the US in 2014 differed
from others, with signature mutations M291T, V341A, T860N, D927N, S1108G, and R2005K [13,23,24],
which were also observed in the isolate V12-2268728 in Hong Kong. The genome sequence of this
isolate shared 98% nucleotide identity to those of outbreak strains in the U.S. (subclade B1), supporting
the idea that the EV-D68 epidemic in the US may have originated from strains circulating in Asia a few
years ago [14].
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constructed using the ML method, with bootstrap values calculated from 1000 trees. Sequences for
207 nucleotide positions in each VP4 region (A), 744 nucleotide positions in each VP2 region (B),
705 nucleotide positions in each VP3 region (C), 441 nucleotide positions in each 2A region (D),
297 nucleotide positions in each 2B region (E), 990 nucleotide positions in each 2C region (F),
333 nucleotide posi ions in each 3A–3B region (G), 549 nucleotide position in each 3C region (H)
and 1371 nucleotide positions in each 3D region (I) were included in the analysis. Bootstrap values
expressed as percentag s are shown at the nodes and the scale reflects the number of n cl otide
substitutions per site along the branches. Only bootstrap values >70% are shown. Black squares
indicate the three EV-D68 strains subjected to complete genome sequencing in the present study.
The interclade recombinants from mainland China are highlighted in grey.
On the other hand, p tential recombination events w re identified in two EV-D68 subclade D2
strains from m i land China, as retrieved from the GenBank s rch, during our ana ysis. Examination
of the tree topologies of the other EV-D68 strains revealed that the EV-D68 subclade D2 strains
BCH895A and BJ24 from mainland China were most closely related to the strains of clade A for
VP2 and 2B, while they were most closely related to subclade D1 strains for other gene regions
(Figures 1A and 3), indicating that recombination events might have occurred in the two subclade
D2 strains. Similarity plot and bootscan analyses, using the BCH895A strain as a query sequence,
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were performed to identify potential recombination sites (Figure 4). The analyses demonstrated
that four recombination sites were probably located at VP4–VP2 (between nucleotide positions
900 and 1300), VP2–VP3 (between nucleotide positions 1500 and 1800), 2A–2B (between nucleotide
positions 3500 and 3800), and 2B–2C (between positions 4000 and 4300). The region between the
VP4–VP2 and VP2–VP3 junctions and the region between the 2A–2B and 2B–2C junctions of the
D2 strain were highly similar to the clade A strain, while other regions were most closely related
to the D1 strain. Potential recombination within the genome sequences was also examined by the
Recombination Detection Program (RDP4). Recombination events were detected in the genome
sequence of the strains BCH895A and BJ24, supported by p values of less than 0.05 in the GENECONV,
Bootscan, and SiScan methods. Two significant recombination breakpoints were identified in the VP2
gene at nucleotide positions 1297 and 1506. While the similarity plot and bootscan analysis supported
the recombination event in the 2B region, this lacked statistical support by RDP4. The above findings
suggested that the two EV-D68 D2 strains BCH895A and BJ24 identified in mainland China in 2008
represent interclade recombinants with the VP2 acquired from clade A.
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Figure 4. Recombination analysis of the complete genome of EV-D68. Bootscan analysis (upper
panel) and similarity plot (lower panel) were conducted with SimPlot version 3.5.1 (Kimura distance
model; window size, 500 bp; step, 20 bp) on a gapless nucleotide alignment, generated with Clustal
X version 2.0 (University College Dublin, Dublin, Ireland), with the genome sequence of the EV-D68
strain BCH895A as a query sequence. The red line denotes EV-D68 subclade D1 strain US/KY/14-18953
and the gr en line denotes EV-D68 clad A strain CA/RESP/10-786. Arrows indicate the gene regions
in which potential recombination breakpoints are located.
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3. Discussion
This study reported the first fatal case associated with EV-D68 infection in Hong Kong.
The 10-year-old boy (case 1) presented with acute encephalitis and deteriorated rapidly after admission.
Although co-infection by M. pneumoniae might have contributed to the encephalitis, the role of
EV-D68 in his illness or exacerbating the mycoplasma infection cannot be excluded. Evidence of
neurological complications associated with EV-D68 infection is increasing in recent epidemiological
investigations [25–27], and the absence of EV-D68 in CSF in the present case may be due to delayed
specimen collection and was consistent with previous reports [26,27]. The failure to detect EV-D68 in
CSF is not surprising as other known neurotropic enteroviruses, like EV-A71 and poliovirus, were not
always detected from CSF specimens of patients with neurological complications, while other specimen
types such as throat swabs, rectal swabs, or stool specimens gave higher diagnostic yields [13,28–31].
Another possible reason is that the neurological symptoms are caused by an aberrant immune response
to EV-D68 infection [13]. On the other hand, the detection of EV-D68 in CSF from patients with
neurological complications has been reported in two cases [32,33], suggesting the possibility of
direct viral neuroinvasion. The latest study demonstrated that EV-D68 strains from the US 2014
outbreak could cause motor neuron death and produce paralytic disease in mice resembling human
acute flaccid myelitis (AFM), supporting the causative role of EV-D68 in neurological diseases [34].
Further investigation is therefore needed to delineate whether an indirect immune effect and/or direct
damage to the neuron is the key mechanism of causing neurological symptoms by EV-D68 infection.
Nevertheless, the two pathogenic mechanisms may not contradict each other, as both processes may
co-exist to cause pathologies, as in many other pathogens. Recent studies have shown that neurological
symptoms were associated with EV-D68 subclade B3 strains. An outbreak of EV-D68 subclade B3
mainly involving children was reported in Sweden, in which some patients had severe respiratory
or neurological symptoms and one died [35]. In another study describing an upsurge of EV-D68 in
the Netherlands, some infected children required intensive care unit admission due to respiratory
insufficiency and one had AFM that were associated with EV-D68 subclade B3 strains [36]. In Italy,
an AFM case that was probably caused by the EV-D68 B3 strain was also reported recently [37].
Unfortunately, the VP1 gene sequence of the EV-D68 strain (V14-8157864) from the present fatal
case could not be amplified probably due to low viral load. We have attempted to propagate this
strain in cell culture, but were unsuccessful. Yet, the partial 5′UTR and 2C sequences of this strain
were 100% identical to those of the subclade B3 strain V14-8151546 (case 10). Interestingly, these two
strains, together with the strains identified in the other five young children (cases 5–9), were detected
during the summer of 2014, suggesting that similar B3 strains may have been predominating in
our population. This is in line with our previous study showing that EV-D68 subclade B3 was the
predominant lineage circulating in Hong Kong since 2014 [14]. In fact, subclade B3 strains were also
detected in Taiwan in 2014 [22]. It is likely that the recent outbreaks of EV-D68 due to subclade B3 in
Europe may have originated from strains that emerged in Asia in 2014. Clinicians should be aware of
the possible neurological manifestations of EV-D68 infection, which may help better understand the
pathogenicity of the emerging subclade B3 strains. The six mutations (M291T, V341A, T860N, D927N,
S1108G, and R2005K) associated with neurovirulence in the US outbreak strains (subclade B1 strains
in 2014) [13,23,24] were noted in the B1 strain, but not in the B3 strain in the present study. Further
studies are required to examine the role of these mutations in the pathogenicity caused by EV-D68.
The previously recognized subclade A2 strains should be re-designated as subclade D1 within
clade D. Current taxonomy and classification of picornaviruses, including enteroviruses, are based
on the capsid region, particular VP1 [38–40]. In the present study, we have determined the pairwise
nucleotide identities using VP1 gene sequences of EV-D68 strains, with the results showing that
the average nucleotide sequence divergences between clades and between subclades were 10.8%
(6.5–14.8%) and 4.7% (2.6–7.1%), respectively (Table 2). As the average nucleotide divergence between
clade A and “A2” strains was 8.4%, together with the evidence from the VP1 sequence and phylogenetic
analyses (Figures 1A and 3), all these findings suggested that the “A2” strains should belong to
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clade D, which has been proposed by other authors [21,22]. Among the clade D strains, two distinct
clusters were shown in the phylogenetic tree of VP1 (Figure 1A) and they had an average nucleotide
divergence of 5.1% (Table 2). Furthermore, amino acid differences were noted in the VP1 of the strains
between these two clusters (Table 3). Therefore, the strains of clade D should be further divided
into subclades D1 and D2. In this study, one subclade D1 strain was detected in the elderly (case 4)
with pneumonia, which is in line with our previous study showing that adults/the elderly in Hong
Kong were exclusively infected by subclade D1 (“A2”) [14]. Although subclade D1 strains have been
circulating globally [22,36,41], the clinical characteristics of patients infected by these strains were not
reported in other studies. Further epidemiological investigations on subclade D1 strains are needed
to determine if this lineage also has a predilection for infecting adults/the elderly in other countries
or continents.
We described the first evidence for interclade recombination in EV-D68. Recombination is
a well-known phenomenon in enterovirus evolution and recombination breakpoints have been
frequently detected in non-structural regions of enterovirus genomes [18,42–44]. This is possibly
because the non-structural genes are highly conserved at certain regions among the same enterovirus
species when compared to structural (capsid) genes. Nevertheless, natural recombination in the
capsid region of polioviruses has also been reported [45,46]. To date, only one study has demonstrated
recombination between subclades B1 and B2 in an EV-D68 strain from the US during the 2014 outbreak,
with a breakpoint in VP2 [19]. In the present study, recombination in capsid region was identified
in two EV-D68 strains (BCH895A and BJ24) belonging to subclade D2 from mainland China in 2008.
Both phylogenetic and recombination analyses showed that the nucleotide sequences of the two
subclade D2 strains from mainland China were most closely related to those of clade A strains in VP2,
but to those of clade D strains in other genomic regions, suggesting that interclade recombination
had occurred between clade A and D strains of EV-D68. Such recombination is not unexpected since
the capsid regions are sufficiently conserved among different clades of a single enterovirus genotype.
Though the association between natural enterovirus recombination and pathogenicity remains unclear,
an in vitro study showed that replacing a structural region of a slow-growth EV-A71 strain with that
of a fast-growth EV-A71 strain could generate a recombinant virus with growth improvement and
larger plaque phenotypes [47]. Further studies are warranted to investigate the role of recombination
in driving the evolution of EV-D68.
In conclusion, we described the molecular epidemiology of EV-D68 in Hong Kong and presented
further evidence for taxonomic reclassification of subclade A2 into a separate clade D1. We also showed
for the first time that recent subclade D2 strains from mainland China probably originated from an
interclade recombination event between clade A and clade D strains. Further evolutionary analysis
of currently circulating EV-D68 strains in East Asia is warranted. Continuous epidemiological and
laboratory surveillance is required to detect novel variants with epidemic potential.
4. Materials and Methods
4.1. Clinical Specimens
NPAs or NPSs were collected from 10 hospitalized patients from seven regional hospitals in Hong
Kong during the years from 2012–2014 (Table 1). EV-D68 detection and isolation from NPAs or NPSs
was performed at the Public Health Laboratory Centre, Centre for Health Protection, Department of
Health, Hong Kong. Detection of EV-D68 RNA from clinical specimens was performed using real-time
RT-PCR targeted to the 5′UTR region and sequencing using a previously described protocol [48].
Isolation of EV-D68 was performed using the human embryonal rhabdomyosarcoma (RD) cell line.
The clinical features, laboratory results, and outcome of illness of these patients were analyzed.
The ethical approval was obtained from the Institutional Review Board of the University of Hong
Kong/Hospital Authority Hong Kong West Cluster (UW 16-365; approval date: 20 July 2016) for
this study.
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4.2. RNA Extraction
The clinical specimens (200 µL each) were subjected to total nucleic acid extraction by the EZ1
Virus Mini Kit v2.0 (QIAGEN, Hilden, Germany), with the elution volume of 60 µL. The eluate was
used as a template for reverse-transcription polymerase chain reaction (RT-PCR).
4.3. Reverse-Transcription Polymerase Chain Reaction (RT-PCR) and Sequencing of VP1 of EV-D68 for
Clade Determination
RT was performed using random hexamers and a SuperScript III Kit (Invitrogen, Carlsbad,
CA, USA) as described previously [14,18]. The VP1 of EV-D68 strains detected from the clinical
specimens were amplified and sequenced using the primers and the strategy described in our previous
publication [14]. Both strands of PCR products were sequenced twice with an ABI 3130xl DNA Analyzer
(Applied Biosystems, Foster City, CA, USA) using the PCR primers. A phylogenetic tree of the VP1
was constructed using maximum likelihood (ML) method in MEGA6 with the model T92 + I [49],
with bootstrap analysis of 1000 replicates. The percentage of VP1 nucleotide sequence identity was
determined by MatGAT2.01 software (Montclair State University, Montclair, NJ, USA) [50].
4.4. RT-PCR and Sequencing of Partial 5′UTR and 2C of EV-D68 and Phylogenetic Analysis
Due to the unsuccessful amplification of the VP1 of the EV-D68 strain V14-8157864 from the fatal
case, we attempted to amplify and sequence the partial 5′UTR and 2C of this strain, together with
the EV-D68 strains detected from the other 9 patients using the primers and the strategy described in
our previous publication [14]. Phylogenetic trees of each region were constructed using ML method
in MEGA6 with the model K2 + G for partial 5′UTR and T92 + I for partial 2C [49], with bootstrap
analysis of 1000 replicates.
4.5. Complete Genome Sequencing of EV-D68
The complete genomes of three EV-D68 strains (V12-2268728, V13-2245157, and V14-8151546) were
amplified and sequenced using the strategy described in our previous publications [18,51]. The cDNA
was synthesized using the viral RNA by a combined random-priming and oligo(dT) priming strategy.
PCR amplification was achieved by degenerate primers designed by multiple alignments of the
EV-D68 genomes and other primers designed based on the results of the first and subsequent rounds of
sequencing. The primer sequences are available upon request. The 5′ ends of the EV-D68 genomes were
confirmed by rapid amplification of cDNA ends (RACE) using Terminal Deoxynucleotidyl Transferase,
recombinant (Invitrogen, Carlsbad, CA, USA). Sequences were assembled and manually edited to
produce final sequences of the viral genomes by BioEdit version 7.2.5 (NC State University, Raleigh,
NC, USA).
4.6. Genome Analysis
The nucleotide sequences of various genomic regions of the EV-D68 strains detected in Hong Kong
were compared to those of EV-D68 strains with available genome sequences in GenBank (Table A1).
Phylogenetic tree construction was performed using the ML method in MEGA6 with the models T92
+ G for VP4, VP2, 2B, 3A-3B, and 3C, and T92 + I for VP3, VP1, 2A, 2C, and 3D (Figures 1A and 3),
with bootstrap values calculated from 1000 trees [49]. Recombination analysis was conducted using a
nucleotide alignment of the genome sequences of the EV-D68 strains in this study, EV-D68 prototype
strain Fermon (original), strain CA/RESP/10-786 (clade A), strain US/KY/14-18953 (clade D1), strain
US/CO/13-60 (clade B1), strain NY73 (clade B2), strain Beijing-R0132 (clade B3), and strain JPOC10-290
(clade C) was generated by ClustalX version 2.0 [52], and edited manually. Once aligned, similarity
plot and bootscan analyses were performed using SimPlot version 3.5.1 (National Institute of Virology,
Pune, India) (window size, 500 bp; step, 20 bp) [53]. Potential recombination within the genome
sequences of EV-D68 was also examined by the Recombination Detection Program version 4.46 (RDP4)
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(University of Cape Town, Cape Town, South Africa) [54]. Phylogenetic incongruence between
different regions and with p values of less than 0.05 in the methods further supported the presence of
recombination events.
4.7. Nucleotide Sequence Accession Numbers
The complete genome sequences of the three EV-D68 strains and the VP1, partial 5′UTR, and 2C
sequences of the EV-D68 strains (Table 1) have been deposited in the GenBank database under accession
numbers KY767820 to KY767842.
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Abbreviations
AFM Acute flaccid myelitis
CVA Cerebrovascular accident
CSF Cerebrospinal fluid
EV-D Enterovirus species D
HT Hypertension
kbp Kilobase pairs
ML Maximum likelihood
MRMP Macrolide-resistant Mycoplasma pneumoniae
MRSA Methicillin-resistant Staphylococcus aureus
NPA Nasopharyngeal aspirate
NPS Nasopharyngeal swab
RACE Rapid amplification of cDNA ends
RD Rhabdomyosarcoma
RDP Recombination Detection Program
RSV Respiratory syncytial virus
RT-PCR Reverse transcription polymerase chain reaction
URTI Upper respiratory tract infection
US United States
UTR Untranslated region
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Appendix A
Table A1. List of EV-D68 strains used for analysis in the present study.
Strain Year of Isolation Place of Isolation Clade * Source GenBank Accession No.
Fermon (prototype) 1962 USA Original GenBank AY426531
CA/RESP/10-786 2013 USA A GenBank KM892500
NYC403 2009 USA A GenBank JX101846
NZ-2010-541 2010 NZ A GenBank JX070222
HK2/2010 2010 HK A GenBank
KT959174 (VP1),
KT959114 (2C)
TW-02378_2010 2010 TW A GenBank KP657713 (VP1)
ITA/19391/12 2012 Italy A GenBank KC763159 (VP1)
2011-21282 2011 China B1 GenBank KT285320
HK8/2011 2011 HK B1 GenBank
KT959180 (VP1),
KT959120 (2C)
HK14/2012 2012 HK B1 GenBank
KT959186 (VP1)
KT959126 (2C)
HK26/2014 2014 HK B1 GenBank
KT959198 (VP1),
KT959138 (2C)
NY316 2014 USA B1 GenBank KP745764
STL_2014_12 2014 USA B1 GenBank KM881710
US/CO/13-60 2013 USA B1 GenBank KP100794
US/CO/14-93 2014 USA B1 GenBank KP126911
US/MO/14-18950 2014 USA B1 GenBank KM851228
NY73 2014 USA B2 GenBank KP745768
NY74 2014 USA B2 GenBank KP745769
US/KY/14-18951 2014 USA B2 GenBank KM851229
US/IL/14-18952 2014 USA B2 GenBank KM851230
2014-R0672 2014 China B3 GenBank KT280500
Beijing-R0132 2014 China B3 GenBank KP240936
HK25/2014 2014 HK B3 GenBank
KT959197 (VP1),
KT959137 (2C)
HK28/2014 2014 HK B3 GenBank
KT959200 (VP1),
KT959140 (2C)
TW-00932-2014 2014 TW B3 GenBank KT711081
TW-00785-2014 2014 TW B3 GenBank KT711083
NY10_16 2016 USA B3 GenBank KX957754
USA/FL/2016-19504 2016 USA B3 GenBank KX675261
SWE_003_2016 2016 SWE B3 GenBank KY215829 (VP4)
SWE_015_2016 2016 SWE B3 GenBank KY215841 (VP4)
USA/U2221/2008 2008 USA C GenBank KX255371
USA/MO93/2009 2009 USA C GenBank KX261814
JPOC10-290 2010 Japan C GenBank AB601882
JPOC10-378 2010 Japan C GenBank AB601883
2011-21286 2011 China D1 GenBank KT306743
2012-12225 2012 China D1 GenBank KT285319
2013-1017-26 2013 China D1 GenBank KT280501
HK5/2011 2011 HK D1 GenBank
KT959177 (VP1),
KT959117 (2C)
HK13/2012 2012 HK D1 GenBank
KT959185 (VP1),
KT959125 (2C)
HK21/2013 2013 HK D1 GenBank
KT959193 (VP1),
KT959133 (2C)
US/KY/14-18953 2014 USA D1 GenBank KM851231
TW-02722_2013 2013 TW D1 GenBank KP657720 (VP1)
BCH895A 2008 China D2 GenBank KF726085
BJ24 2008 China D2 GenBank KU242683
1737-Yamagata-2008 2008 Japan D2 GenBank AB667899 (VP1)
TW-01166_2007 2007 TW D2 GenBank KP657701 (VP1)
TW-11134_2009 2009 TW D2 GenBank KP657708 (VP1)
V12-2240471 2012 HK B1 This study
KY767823 (VP1),
KY767829 (5′UTR),
KY767836 (2C)
V12-2268728 2012 HK B1 This study KY767820
V13-2245157 2013 HK D1 This study KY767821
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Table A1. Cont.
Strain Year of Isolation Place of Isolation Clade * Source GenBank Accession No.
V14-8133616 2014 HK B3 This study
KY767824 (VP1),
KY767830 (5′UTR),
KY767837 (2C)
V14-8135150 2014 HK B3 This study
KY767825 (VP1),
KY767831 (5′UTR),
KY767838 (2C)
V14-8143594 2014 HK B3 This study
KY767826 (VP1),
KY767832 (5′UTR),
KY767839 (2C)
V14-8143833 2014 HK B3 This study
KY767827 (VP1),
KY767833 (5′UTR),
KY767840 (2C)
V14-8151518 2014 HK B3 This study
KY767828 (VP1),
KY767834 (5′UTR),
KY767841 (2C)
V14-8151546 2014 HK B3 This study KY767822
V14-8157864 2014 HK B3 # This study
KY767835 (5′UTR),
KY767842 (2C)
# VP1 sequence not available; partial 5’UTR and 2C were sequenced (100% identical to those of EV-D68 strain
V14-8151546; potential subclade B3). Abbreviations: HK, Hong Kong; NZ, New Zealand; SWE, Sweden; TW, Taiwan;
USA, the United States of America.
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